CN105661487A - Healthcare product for women in menstrual period - Google Patents
Healthcare product for women in menstrual period Download PDFInfo
- Publication number
- CN105661487A CN105661487A CN201610073204.7A CN201610073204A CN105661487A CN 105661487 A CN105661487 A CN 105661487A CN 201610073204 A CN201610073204 A CN 201610073204A CN 105661487 A CN105661487 A CN 105661487A
- Authority
- CN
- China
- Prior art keywords
- parts
- semen
- wulf
- health product
- fructus lycii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003821 menstrual periods Effects 0.000 title abstract description 3
- 239000002994 raw material Substances 0.000 claims abstract description 32
- 230000011599 ovarian follicle development Effects 0.000 claims abstract description 8
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 7
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims description 85
- 230000036541 health Effects 0.000 claims description 47
- 241000233866 Fungi Species 0.000 claims description 14
- 235000009392 Vitis Nutrition 0.000 claims description 14
- 241000219095 Vitis Species 0.000 claims description 14
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 9
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 9
- 235000021014 blueberries Nutrition 0.000 claims description 9
- 235000021028 berry Nutrition 0.000 claims description 8
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 6
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 6
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 6
- 235000004634 cranberry Nutrition 0.000 claims description 6
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 241000169546 Lycium ruthenicum Species 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract description 9
- 210000001672 ovary Anatomy 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 230000008217 follicular development Effects 0.000 abstract description 3
- 230000003796 beauty Effects 0.000 abstract description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000000231 Sesamum indicum Species 0.000 abstract 1
- 235000003434 Sesamum indicum Nutrition 0.000 abstract 1
- 235000013305 food Nutrition 0.000 description 10
- 229920001503 Glucan Polymers 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 6
- 244000077233 Vaccinium uliginosum Species 0.000 description 5
- 210000004696 endometrium Anatomy 0.000 description 5
- 230000002175 menstrual effect Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 229920002498 Beta-glucan Polymers 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 229940011871 estrogen Drugs 0.000 description 4
- 239000000262 estrogen Substances 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 210000004602 germ cell Anatomy 0.000 description 3
- 230000016087 ovulation Effects 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000029849 luteinization Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000027758 ovulation cycle Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241001327634 Agaricus blazei Species 0.000 description 1
- 240000007440 Agaricus campestris Species 0.000 description 1
- 241000221377 Auricularia Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 241001537207 Flammulina Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 240000000588 Hericium erinaceus Species 0.000 description 1
- 235000007328 Hericium erinaceus Nutrition 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 240000002769 Morchella esculenta Species 0.000 description 1
- 235000002779 Morchella esculenta Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000760198 Russula vinosa Species 0.000 description 1
- 241000272503 Sparassis radicata Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010041954 Starvation Diseases 0.000 description 1
- 241000231230 Suillus bovinus Species 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 240000006794 Volvariella volvacea Species 0.000 description 1
- 235000004501 Volvariella volvacea Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000002503 granulosa cell Anatomy 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 230000001294 luteotrophic effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 208000005368 osteomalacia Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- -1 starch etc. Chemical compound 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/44—Coffee substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A healthcare product for women in the menstrual period is prepared from raw material in parts by weight as follows: 10-20 parts of edible mushrooms, 5-20 parts of fructus lycii, 2-15 parts of Chinese yam, 2-15 parts of sesame, 15-30 parts of nuts and 0.5-1.2 parts of an antioxidant. The healthcare product can realize the functions of nourishing Yin, moistening dryness and replenishing and nourishing blood, nourishes the ovary to facilitate follicular development, is anti-oxidative and beneficial to skin and maintains beauty when taken by women in the follicular phase.
Description
Technical field
The invention belongs to field of health care products, particularly relate to the health product that a kind of women physiological period is taken.
Background technology
Determining female physiological periodicity be divided into menstrual phase, follicular phase and luteal phase three phases. The women of child-bearing age are left and right every other month, and endometrium occurs once independently to thicken, and the growth of blood vessel hyperplasia, body of gland is secreted and endometrium collapse comes off and with hemorrhage cyclically-varying, this periodicity vaginal haemorrhage or metrorrhagia phenomenon are called menstruation. The method that menstrual cycle calculates is within first day, to count from a upper menstruation, after 28 days, exactly second time menstrual phase starts, but due to the difference of body constitution, age, weather, area and living condition, and menstrual cycle also can difference to some extent, before and after 28 days in the scope of 7 days, all belong to normal range. Follicular phase, this phase to ovary ovulation day only, lasted 10～12 days by ischomenia day last time. Interim at this, the granulosa cell of this phase follicle produces estrogen under the effect of follicule-stimulating hormone (FSH) and lutropin, and under the effect of estrogen, endometrium is bred rapidly, blood vessel hyperplasia, the broadening lengthening of body of gland, but does not secrete. In this end of term, ovary is ovulated. Luteal phase, arriving the previous day of menstrual onset after referring to ovulation, ovary is by the impact of luteotrophic hormone, secretion lutein, maintains the endometrium thickened, in order to germ cell work bed, if without germ cell work bed, endometrium will disintegrate, physiological period with work menstrual onset terminate. The 15th～28 day of physiological period, generally lasts for 14 days, and now in ovary, follicular development is ripe, and ovulation gradually forms corpus luteum. In this end of term, endometrial growth culminates, and plantation and continuation growth for germ cell have prepared condition.
Health care is nursed one's health at present, although have some medicines and food, but the health-care effect to women is not especially desirable about the health of determining female physiological periodicity.
Summary of the invention
In view of this, it is an object of the invention to propose the health product that a kind of women physiological period is taken, it is possible to the feature for determining female physiological periodicity is provided with conditioning targetedly and health care.
In order to some aspects of the embodiment disclosed are had a basic understanding, shown below is simple summary. This summarized section is not extensive overview, neither determine key/critical component or describe the protection domain of these embodiments. Its sole purpose is to present some concepts by simple form, in this, as the preamble of following detailed description.
In some illustrative embodiment, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: edible fungi 10～20 parts;Fructus Lycii 5～20 parts; Rhizoma Dioscoreae 2～15 parts; Semen Sesami 2～15 parts; Nut 15～30 parts; Antioxidant 0.5～1.2 part.
In some illustrative embodiment, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: edible fungi 10～20 parts; Fructus Lycii 5～20 parts; Rhizoma Dioscoreae 2～15 parts; Semen Sesami 2～15 parts; Nut 15～30 parts.
Wherein, described edible fungi is Sparassia crispa (Wulf.) Fr.; Described Fructus Lycii is Lycium ruthenicum Murr. or red Fructus Lycii; Described nut is Semen Caryae Cathayensis or Semen Juglandis or semen juglandis; Described Semen Sesami is Semen Sesami Nigrum or Semen sesami Albae; Described antioxidant is Semen Vitis viniferae or the certain kind of berries.
In some illustrative embodiment, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 11～15 parts; Fructus Lycii 10～15 parts; Rhizoma Dioscoreae 5～10 parts; Semen Sesami Nigrum 5～10 parts; Semen Caryae Cathayensis 20～25 parts; Semen Vitis viniferae 1 part.
In some illustrative embodiment, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 11～15 parts; Fructus Lycii 10～15 parts; Rhizoma Dioscoreae 5～10 parts; Semen Sesami Nigrum 5～10 parts; Semen Caryae Cathayensis 20～25 parts; The certain kind of berries 1 part.
In some illustrative embodiment, described Sparassia crispa (Wulf.) Fr. is Sparassia crispa (Wulf.) Fr.-H, Sparassia crispa (Wulf.) Fr.-X or Sparassia crispa (Wulf.) Fr.-G; The described certain kind of berries is blue berry or cranberry.
In some preferred embodiments, the weight fraction of described Sparassia crispa (Wulf.) Fr. is 12 parts.
In some illustrative embodiment, each raw material is processed to powdery and makes capsule, tablet or electuary.
Preferably, described health product women took in follicular phase.
For above-mentioned and relevant purpose, one or more embodiments include the feature that will be explained in below and be particularly pointed out in the claims. Description below describes some illustrative aspects and some modes in the utilizable various modes of principle of only each embodiment of its instruction in detail. Other benefit and novel features will become apparent upon along with detailed description below, and the disclosed embodiments are to include all these aspects and theirs is equivalent.
Detailed description of the invention
It is described below and specific embodiments of the present invention are shown fully, to enable those skilled in the art to put into practice them. The scope of embodiment of the present invention includes the gamut of claims and all obtainable equivalent of claims. In this article, these embodiments of the present invention can be represented individually or generally with term " invention ", this is only used to conveniently, and if in fact disclose the invention of more than one, what be not meant to automatically to limit this application ranges for any single invention or inventive concept.
Follicular phase is named postmenstruation again. Through after the initial stage, health is after a menstruation, and one section of inanition of the sea of blood, growing of YIN edema is also very slow, at this moment it is noted that vital essence replenishing, helps it to recover. During menstrual onset, health can lose a part of blood. The main component of blood has the inorganic salts such as plasma protein, potassium, ferrum, calcium, magnesium, all can lose a part of protein and inorganic salt so every time in the period. Therefore, say in principle, in 1-5 days after clean period, the nutrient substance such as protein, mineral should be supplemented and use some hematonic, not only can benefit skin beauty treatment but also have the food of effect of replenishing and activating blood just to become first-selection with medicine. Due to the effect of internal estrogen and Progesterone, in different physiological periods, the state of skin also can be different. In after menstrual period terminate 7 days, estrogen and Progesterone element all can experience relative violent change, be now skin metabolism the most quickly, absorb nutrient best time, so being now women " defying age golden period ".
The golden period enriched blood in seven days after menstruation, owing to intermenstrual period lost irony, protein, inorganic salt etc., so diet should eat more rich in ferrum, calcium, magnesium, protein food. Common nourishing YIN and supplementing blood food has the food iron content such as meat, Fish and various animal liver, blood, lean meat, egg yolk to enrich. Grain based food, including fructus zizaniae caduciflorae, Semen sojae atricolor, Semen Sesami, Ipomoea batatas Lam. etc. Greengrocery food, including Herba Spinaciae, Rhizoma Nelumbinis, mushroom, Auricularia, Tremella etc.
Feature according to this stage, in certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 11～15 parts; Fructus Lycii 10～15 parts; Rhizoma Dioscoreae 5～10 parts; Semen Sesami Nigrum 5～10 parts; Semen Caryae Cathayensis 20～25 parts; Semen Vitis viniferae 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 11～15 parts; Fructus Lycii 10～15 parts; Rhizoma Dioscoreae 5～10 parts; Semen Sesami Nigrum 5～10 parts; Semen Caryae Cathayensis 20～25 parts; Blue berry 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 10 parts; Rhizoma Dioscoreae 5 parts; Semen Sesami Nigrum 10 parts; Semen Juglandis 20 parts; Semen Vitis viniferae 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 10 parts; Rhizoma Dioscoreae 10 parts; Semen Sesami Nigrum 5 parts; Semen Juglandis 20 parts; Semen Vitis viniferae 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 12 parts; Rhizoma Dioscoreae 9 parts; Semen Sesami Nigrum 5 parts; Semen Juglandis 20 parts; Semen Vitis viniferae 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 12 parts; Rhizoma Dioscoreae 5 parts; Semen Sesami Nigrum 9 parts; Semen juglandis 20 parts; Semen Vitis viniferae 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 10 parts; Rhizoma Dioscoreae 5 parts; Semen Sesami Nigrum 5 parts; Semen juglandis 25 parts; Semen Vitis viniferae 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 15 parts; Rhizoma Dioscoreae 5 parts; Semen Sesami Nigrum 5 parts; Semen juglandis 20 parts; Semen Vitis viniferae 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 12 parts; Rhizoma Dioscoreae 5 parts; Semen Sesami Nigrum 5 parts; Semen Juglandis 23 parts; Semen Vitis viniferae 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 10 parts; Rhizoma Dioscoreae 5 parts; Semen Sesami Nigrum 10 parts; Semen Juglandis 20 parts; Blue berry 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 10 parts; Rhizoma Dioscoreae 10 parts; Semen Sesami Nigrum 5 parts; Semen Caryae Cathayensis 20 parts; Blue berry 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 12 parts; Rhizoma Dioscoreae 9 parts; Semen Sesami Nigrum 5 parts; Semen Juglandis 20 parts; Blue berry 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 12 parts; Rhizoma Dioscoreae 5 parts; Semen Sesami Nigrum 9 parts; Semen juglandis 20 parts; Blue berry 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 10 parts; Rhizoma Dioscoreae 5 parts; Semen Sesami Nigrum 5 parts; Semen Juglandis 25 parts; Cranberry 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 15 parts; Rhizoma Dioscoreae 5 parts; Semen Sesami Nigrum 5 parts; Semen Caryae Cathayensis 20 parts; Cranberry 1 part.
In certain embodiments, the health product that described women physiological period is taken are made up of following raw materials by weight portion ratio: Sparassia crispa (Wulf.) Fr. 12 parts; Fructus Lycii 12 parts; Rhizoma Dioscoreae 5 parts; Semen Sesami Nigrum 5 parts; Semen juglandis 23 parts; Cranberry 1 part.
In certain embodiments, each raw material is processed to powdery and makes capsule. Such as, coffee capsule is made with 1.2 grams of silk ball mycopowder, 1 gram of Fructus Lycii powder, 0.5 Keshan medicated powder, 1 gram of Semen Sesami Nigrum powder, 2 grams of Semen Juglandis powder and 0.1 gram of Semen Vitis viniferae.
Those skilled in the art are it is easily guessed that various raw material can also be processed to the health product of tablet, electuary or other similar tea-drinking.
Sparassia crispa (Wulf.) Fr., also cries silk ball mushroom, and Classification system is Sparassiscrispa, is non-pleat pore fungi order, silk ball Cordycepps, silk ball Pseudomonas. Because it has the activation immunocompetence of superelevation, there is the title of " the magical mushroom of illusion " in Japan. Common mushroom growth is at the back, and the irradiation that silk ball mushroom needs more than 10 hours every day, it is unique " sunlight mushroom " in the world. American-European, Japanese in great demand, expensive. The maximum feature of Sparassia crispa (Wulf.) Fr. is that every 100 grams of Sparassia crispa (Wulf.) Fr. contain beta glucan up to 43.6 grams, exceed 3～4 times than Ganoderma and Agaricus blazei Murrill containing a large amount of beta glucans. It can be said that the beta glucan contained by Sparassia crispa (Wulf.) Fr. be mushrooms. Glucosan is the polysaccharide being polymerized by glucose monomer, is divided into α type and β type, α type glucosan such as starch etc., is the main source of human body energy, does not possess biological activity. β type glucosan is a kind of bioactive substance, confirms through medical research, the several functions such as have immunomodulating, antitumor, antiinflammatory, antiviral, antioxidation, radioprotective, blood sugar lowering, blood fat reducing, protect the liver. Research also finds, it is all β (1-3) the D glucosan with β (1-6) glycosidic bond branch that great majority have the polysaccharide of anti-tumor activity. There are some researches prove, β (1-3) the D glucosan from fungus is generally of the function of tumor of suppression. Macrodex % in Sparassia crispa (Wulf.) Fr. is above β (1-3) D glucosan, has good antitumor, immunomodulating and improves the effects such as hemopoietic function. Sparassia crispa (Wulf.) Fr. contains a large amount of vitamin and mineral Sparassia crispa (Wulf.) Fr. contains vitamin C, vitamin E, and its content of vitamin E occupies Homonemeae food prostatitis, and these vitamin have antioxidation. Sparassia crispa (Wulf.) Fr., possibly together with ergosterol, can be changed into vitamin D under sunlight and ultraviolet radiation, can promote Calcium and phosphorous absorption, be conducive to skeleton to be formed, prevention children rachitis, adult's osteoporosis and osteomalacia. Sparassia crispa (Wulf.) Fr. contains at a relatively high potassium element, and the content of sodium is relatively low, and this hyperkalemia hyponatremia food has diuresis, is highly beneficial to hyperpietic. Sparassia crispa (Wulf.) Fr. contains the free radical in a large amount of antioxidant human body and biological cell oxidative damage can be caused to cause organism aging process, and destroys disease-resistant, the defence capability of body, causes cancer and cardiovascular disease chronic diseases. Nowadays, the oxidation resistance of natural food has been subjected to the most attention of people, and wherein, superoxide dismutase (SOD) can the effective free radical in purged body, it is prevented that the active oxygen injury to body, antioxidation, defying age effect.According to surveying and determination, in Sparassia crispa (Wulf.) Fr., the content of superoxide dismutase occupies first of various edible fungi.
The new varieties of the domestic Sparassia crispa (Wulf.) Fr. cultivated, include but not limited to Sparassia crispa (Wulf.) Fr.-H, Sparassia crispa (Wulf.) Fr.-X or Sparassia crispa (Wulf.) Fr.-G etc., are suitable for each embodiment at present.
Finding through big quantity research, Sparassia crispa (Wulf.) Fr. owing to containing a large amount of beta glucans, therefore having obvious blood nourishing function, being remarkably contributing to the conditioning of human endocrine to human body. Women follicular phase (the 7th～14 day of preferred physiological period) take described health product can nourshing Yin and drynsessmoistening prescription blood-supplementing blood-nourishing, nourish ovary be beneficial to follicular development, antioxidation benefit skin improve looks. Described health product women took in follicular phase.
In actual applications, it is also possible to the edible fungi being considered as other replaces Sparassia crispa (Wulf.) Fr..
In certain embodiments, the health product that women physiological period is taken are made up of following raw materials by weight portion ratio: edible fungi 10～20 parts; Fructus Lycii 5～20 parts; Rhizoma Dioscoreae 2～15 parts; Semen Sesami 2～15 parts; Nut 15～30 parts; Semen Vitis viniferae 0.5～1.2 part.
In certain embodiments, the health product that women physiological period is taken are made up of following raw materials by weight portion ratio: edible fungi 10～20 parts; Fructus Lycii 5～20 parts; Rhizoma Dioscoreae 2～15 parts; Semen Sesami 2～15 parts; Nut 15～3 parts; The certain kind of berries 0.5～1.2 part.
In certain embodiments, the health product that women physiological period is taken are made up of following raw materials by weight portion ratio: edible fungi 10～20 parts; Fructus Lycii 5～20 parts; Rhizoma Dioscoreae 2～15 parts; Semen Sesami 2～15 parts; Nut 15～30 parts.
Wherein, nut can be Semen Juglandis, Semen Caryae Cathayensis, semen juglandis, it is preferable that Semen Caryae Cathayensis; Semen Sesami can be Semen Sesami Nigrum can also be Semen sesami Albae, it is preferable that Semen Sesami Nigrum; The certain kind of berries can be blue berry can also be cranberry, it is preferable that blue berry; Edible fungi can be Sparassia crispa (Wulf.) Fr., it is also possible to adopt other strain according to the actual requirements, includes but not limited to Lentinus Edodes, Volvariella volvacea (Bull.Ex Franch.) Singer．, Flammulina velutiper (Fr.) Sing, Hericium erinaceus (Bull. Ex Fr.) Pers., agrocyb eaegerita, bolete, Morchella esculenta (L.) Pers, cherry rivet mushroom, oronge bacterium, suillusbovinus, Russula vinosa Lindbl etc.
The embodiment of invention described herein is illustrative of, and it is conceivable that many corrections, change and adjustment can reach the result being substantially equal, all these are intended to be included in the spirit and scope of the present invention. Additionally, the purpose of above-mentioned summary is to make the general public, particularly it is unfamiliar with this area scientist of patent or law term or wording, engineer and practitioner, by essence and the characteristic that can understand present techniques content rapidly of skimming.
Claims (9)
1. the health product that a women physiological period is taken, it is characterised in that be made up of following raw materials by weight portion ratio:
Edible fungi 10～20 parts;
Fructus Lycii 5～20 parts;
Rhizoma Dioscoreae 2～15 parts;
Semen Sesami 2～15 parts;
Nut 15～30 parts;
Antioxidant 0.5～1.2 part.
2. the health product that a women physiological period is taken, it is characterised in that be made up of following raw materials by weight portion ratio:
Edible fungi 10～20 parts;
Fructus Lycii 5～20 parts;
Rhizoma Dioscoreae 2～15 parts;
Semen Sesami 2～15 parts;
Nut 15～30 parts.
3. health product as claimed in claim 1, it is characterised in that described edible fungi is Sparassia crispa (Wulf.) Fr.; Described Fructus Lycii is Lycium ruthenicum Murr. or red Fructus Lycii; Described nut is Semen Caryae Cathayensis or Semen Juglandis or semen juglandis; Described Semen Sesami is Semen Sesami Nigrum or Semen sesami Albae; Described antioxidant is Semen Vitis viniferae or the certain kind of berries.
4. the health product that a women physiological period is taken, it is characterised in that be made up of following raw materials by weight portion ratio:
Sparassia crispa (Wulf.) Fr. 11～15 parts;
Fructus Lycii 10～15 parts;
Rhizoma Dioscoreae 5～10 parts;
Semen Sesami Nigrum 5～10 parts;
Semen Caryae Cathayensis 20～25 parts;
Semen Vitis viniferae 1 part.
5. the health product that a women physiological period is taken, it is characterised in that be made up of following raw materials by weight portion ratio:
Sparassia crispa (Wulf.) Fr. 11～15 parts;
Fructus Lycii 10～15 parts;
Rhizoma Dioscoreae 5～10 parts;
Semen Sesami Nigrum 5～10 parts;
Semen Caryae Cathayensis 20～25 parts;
The certain kind of berries 1 part.
6. the health product as described in claim 4 or 5, it is characterised in that the parts by weight of described Sparassia crispa (Wulf.) Fr. are 12 parts.
7. the health product as described in claim 3 or 5, it is characterised in that described Sparassia crispa (Wulf.) Fr. is Sparassia crispa (Wulf.) Fr.-H, Sparassia crispa (Wulf.) Fr.-X or Sparassia crispa (Wulf.) Fr.-G; The described certain kind of berries is blue berry or cranberry.
8. the health product as described in any one of claim 1 to 7, it is characterised in that each raw material is processed to powdery and makes capsule, tablet or electuary.
9. the health product as described in any one of claim 1 to 7, it is characterised in that described health product women took in follicular phase.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610073204.7A CN105661487A (en) | 2016-02-02 | 2016-02-02 | Healthcare product for women in menstrual period |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610073204.7A CN105661487A (en) | 2016-02-02 | 2016-02-02 | Healthcare product for women in menstrual period |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105661487A true CN105661487A (en) | 2016-06-15 |
Family
ID=56303273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610073204.7A Pending CN105661487A (en) | 2016-02-02 | 2016-02-02 | Healthcare product for women in menstrual period |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105661487A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102793170A (en) * | 2012-08-30 | 2012-11-28 | 张德敏 | Method for preparing health food with effects of regulating gastrointestinal functions, protecting brain and liver and tonifying kidney |
| CN103815404A (en) * | 2014-03-10 | 2014-05-28 | 张德敏 | Nutritional food according with theory of yin-yang balance of five elements and preparation method of nutritional food |
-
2016
- 2016-02-02 CN CN201610073204.7A patent/CN105661487A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102793170A (en) * | 2012-08-30 | 2012-11-28 | 张德敏 | Method for preparing health food with effects of regulating gastrointestinal functions, protecting brain and liver and tonifying kidney |
| CN103815404A (en) * | 2014-03-10 | 2014-05-28 | 张德敏 | Nutritional food according with theory of yin-yang balance of five elements and preparation method of nutritional food |
Non-Patent Citations (1)
| Title |
|---|
| 马纲，等: "《茶包偏方养生治病一本全》", 30 April 2015 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103919143B (en) | A kind of Roxburgh rose collagen sheet and preparation method thereof | |
| CN106266700A (en) | A kind of Fructus Hippophae prescription bag alveolitoid medicinal tea allotment and manufacture method | |
| CN105341668A (en) | Health-preserving quinoa porridge | |
| CN109550040A (en) | A kind of Chinese medicine peptide composition of strengthen immunity | |
| CN104258063A (en) | Chinese herbal medicinal composition capable of increasing chicken immunity | |
| CN104397800A (en) | Blueberry effervescent instant beverage and preparation method thereof | |
| CN106860680A (en) | Golden flower ginseng pressed candies and preparation method thereof | |
| CN106360335A (en) | Mushroom coarse cereal noodles and making method thereof | |
| CN105384562A (en) | Pleurotus geesteranus medium | |
| CN103518981A (en) | Feed premix for preventing and treating heat stress of sows | |
| CN105707762A (en) | Health-care product administrated in female menstrual period | |
| CN107410855A (en) | A kind of flour of rich in nutrition | |
| KR102448039B1 (en) | A method of manufacturing powder and extract by complex fermentation with red ginseng and ginseng with excellent medicinal properties using mycelium extracted from various mushrooms | |
| KR20200023053A (en) | Powder type multiple food supplement comprising beta glucan powder, chitosan powder, acerola extract powder, ganoderma lucidum fruit body powder, grifola frondosa powder, lentinus edodes mycelium powder, lycium chinense powder, aloe powder, angelica gigas extract powder and ginseng extract powder | |
| CN105661202A (en) | Health-care asparagus drink | |
| CN105661487A (en) | Healthcare product for women in menstrual period | |
| CN104522530A (en) | Health maintaining noodles containing astragalus | |
| CN108522888A (en) | A kind of feed and preparation method thereof for promoting chick growth, improving laying rate of laying hen | |
| CN108617853A (en) | The feed addictive and preparation method for promoting chick growth, improving laying rate of laying hen | |
| CN114128781A (en) | Saussurea involucrata tablet candy and preparation method thereof | |
| CN107950795A (en) | It is a kind of to be used to promote green and healthy feed of piglet fast-growth and preparation method thereof | |
| CN103445168A (en) | Compound trepang particle chewable tablet and preparation method thereof | |
| CN109198601A (en) | A kind of composite fungi albumen powder nutritional food formula | |
| CN107136490A (en) | A kind of peptide Chinese caterpillar fungus health product | |
| CN103230034A (en) | Brown rice powder sausage and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160615 |
|
| RJ01 | Rejection of invention patent application after publication |